Varicela grave: An analysis of compulsory notifications, Brazil 2012 to 2019
DOI:
https://doi.org/10.33448/rsd-v10i2.12026Keywords:
Varicella; Epidemiology; Hoax; Chickenpox vaccine.Abstract
Objective: To describe and analyze the reported cases of severe varicella in Brazil and its social impact on public health. Methodology: This is a transversal observational descriptive study conducted with data collected by DATASUS, based on the survey of sociodemographic and clinical variables, from 2012 to 2019, and analyzed using prevalence calculations and the chi-square association test. Results: Of the 694,809 cases of severe varicella reported in Brazil, 2013 had the highest number of cases (28.51%), with a reduction in 2013 compared to 2019 (91.3%) and an increase of 55,36% from 2018 to 2019. Most cases were male, ranging from 51.15% to 52.31% (p <0.05), white (57.43%), school age group (34.1%) and the Southeast Region (31.47%). There was a clinical classification of the disease in 433,482 cases, most cured (99.8%; p <0.05). The preschool age group was the only one that presented, in 2019, a lower percentage of cases (11.58%) when compared to 2012 (30.35%). Conclusion: The introduction of the varicella vaccine resulted in a drop in the number of cases of the disease, with a socioeconomic impact on public health, and it is still necessary to demystify Fake News about the vaccine to improve vaccination coverage and prevent a new epidemic of the disease.
References
Andrade, A. L., da Silva Vieira, M. A., Minamisava, R., Toscano, C. M., de Lima Souza, M. B., Fiaccadori, F., Figueiredo, C. A., Curti, S. P., Nerger, M. L. B. R., & Bierrenbach, A. L. (2018). Varicella Study Group. Single-dose varicella vaccine effectiveness in Brazil: A case-control study. Vaccine, 36(4), 479-483. 10.1016/j.vaccine.2017.12.011.
Anjos, K. S. D., Ferreira, M. M. E., Arruda, M. D. C., Ramos, K. D. S., & Magalhães, A. P. R. (2009). Caracterização epidemiológica dos casos de varicela em pacientes internados em um hospital universitário da cidade do Recife. Revista Brasileira de Epidemiologia, 12(4), 523-532. 10.1590/S1415-790X2009000400002.
Arlant, L., Garcia, M., Avila Aguero, M. L., Cashat, M., Parellada, C. I., & Wolfson, L. J. (2019). Burden of varicella in Latin America and the Caribbean: findings from a systematic literature review. BMC public health, 19(1), pp.528. 10.1186/s12889-019-6795-0.
Bozzola, E., & Bozzola, M. (2016). Varicella complications and universal immunization. J Pediatr, 92(4), 328-30. 10.1016/j.jped.2016.05.001.
Choo, P. W., Donahue, J. G., Manson, J. E., & Platt, R. (1995). The Epidemiology of Varicella and Its Complications. The Journal of Infectious Diseases, 172(3), 706–712. https://doi.org/10.1093/infdis/172.3.706.
European Centre for Disease Prevention and Control (2015). Varicella vaccination in the European Union. Stockholm. https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/Varicella-Guidance-2015.pdf.
Galetta K. M., & Gilden, D. (2015). Zeroing in on zoster: A tale of many disorders produced by one virus. J Neurol Sci, 358(1-2), 38-45. https://doi.org/10.1016/j.jns.2015.10.004.
Gershon A. A., Breuer J., Cohen J. I., Cohrs R. J., & Gershon M. D., et al. (2015). Varicella zoster virus infection. Nat Rev Dis Primers, 1(1), 15016. https://doi.org/10.1038/nrdp.2015.16.
Gordon, J. E. (1962). Chicken pox: an epidemiologic review. North American Journal of Medical Sciences, 244, 362-370.
Hirose, M., Gilio, A. E., Ferronato, A. E., & Ragazzi, S. L. B. (2016). Impacto da vacina varicela nas taxas de internações relacionadas à varicela: revisão de dados mundiais. Revista Paulista de Pediatria, 34(3), 359-366. 10.1016/j.rppede.2016.03.001.
Lin, F., & Hadler, J. L. (2000). Epidemiology of Primary Varicella and Herpes Zoster Hospitalizations: The Pre–Varicella Vaccine Era. The Journal of infectious diseases, 181, 1897-1905.
Malta, D. C., Prado, R. R., Saltarelli, R. M. F., Monteiro, R. A., Souza, M. F. M., & Almeida, M. F (2019). Mortes evitáveis na infância, segundo ações do Sistema Único de Saúde, Brasil. Revista Brasileira de Epidemiologia, 22, 190014. 10.1590/1980-549720190014.
Marin, M., Marti, M., Kambhampati, A., Jeram, S. M., & Seward, J. F. (2016). Global Varicella Vaccine Effectiveness: A Meta-analysis. Pediatrics, 137(3), 20153741. 10.1542/peds.2015-3741.
Ministério da Saúde, Brasil (2016). Portaria no - 204, de 17 de fevereiro de 2016: Define a Lista Nacional de Notificação Compulsória de doenças, agravos e eventos de saúde pública nos serviços de saúde públicos e privados em todo o território nacional, nos termos do anexo, e dá outras providências. Brasília. 2016. https://bvsms.saude.gov.br/bvs/saudelegis/gm/2016/prt0204_17_02_2016.html.
Ministério da Saúde, Brasil (2018). Nota Informativa nº 135-SEI/MS/2017:Informa as mudanças no Calendário Nacional de Vacinação para o ano 2018. Brasília. 2018. https://saude.es.gov.br/Media/sesa/Imuniza%C3%A7%C3%A3o/SEI_MS%20-%20Nota%20Informativa%20135%20-%20mudancas%20no%20calendario%20nacional%20de%20vacinacao%202018.pdf
Ministério da Saúde, Brasil (2019). Guia de Vigilância em Saúde: volume único. https://portalarquivos2.saude.gov.br/images/pdf/2019/junho/25/guia-vigilancia-saude-volume-unico-3ed.pdf.
Ministério da Saúde, Brasil (2020). DATASUS. Coberturas vacinais segundo macrorregião, 2012-2019. http://tabnet.datasus.gov.br/cgi/dhdat.exe?bd_pni/cpnibr.def.
Moffat J., Ku C. C., Zerboni L., Sommer M., & Arvin A. (2007). VZV: pathogenesis and the disease consequences of primary infection. In: Arvin A., Campadelli-Fiume G., Mocarski E., Moore P.S.,
Ouwendijk W. J., & Verjans G. M. (2015). Pathogenesis of varicelloviruFses in primates. J Pathol. 235, 298-311.
Pereira,A. S., Shitsuka,, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica UAB/NTE/UFSM. https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_Metodologia-Pesquisa-Cientifica.pdf?sequence=1.
Pinto, I. C. T., Diniz, L. M. O., Carvalho, L. K., Resende, L. S., Silva, H. B. A., Araújo, R. F. A., Maia, M. M. M, & Ribeiro, J. G. L. (2020). Avaliação do número de casos e do perfil de internações por varicela em hospital pediátrico após a introdução da vacina. Revista Paulista de Pediatria, 39, e2019215. 10.1590/1984-0462/2021/39/2019215.
Roizman B., Whitley R., Yamanishi K., editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; Chapter. 37
Sanches, S. H. D. F. N., & Cavalcanti, A. E. L. W. (2018). Direito à Saúde na Sociedade da Informação: A Questão das Fake News e seus Impactos na Vacinação. Revista Juridica 3 (52), 448 - 466. 10.21902/revistajur.2316-753X.v53i4.3227.
Santos, V. L. C., & Santos, J. E. (2014). As redes sociais digitais e sua influência na sociedade e educação contemporâneas. Holos, 30(6), 307-328. 10.15628/holos.2014.1936.
Saraiva, L. J. C., & De Faria, J. F. (2019). A Ciência e a Mídia: A propagação de Fake News e sua relação com o movimento anti-vacina no Brasil. https://portalintercom.org.br/anais/nacional2019/resumos/R14-1653-1.pdf.
Sato, A. P. S. (2020). Pandemia e coberturas vacinais: desafios para o retorno às escolas. Rev. Saúde Pública, 54, 115. 10.11606/s1518-8787.2020054003142
Seward, J. F., Marin, M., & Vázquez, M. (2008). Varicella Vaccine Effectiveness in the US Vaccination Program: A Review. The Journal of Infectious Diseases, 197, 82-89. 10.1086/522145
Silva, A. L. M., Gouvêa, J. S., Silva, A. N. M. R., Machado, L. F. A., Monteiro, J. C., Azevedo, V. N., Vallinoto, A. C. R., & Feitosa, R. N. M. (2020). Impact of chickenpox vaccination on morbidity and mortality rates in Brazil. Braz. J. Hea. Rev., 3 (4), 7236-7249.
Succi, R. C. M. (2018). Vaccine refusal - what we need to know. J. Pediatr., 94 (6), 574-581. 10.1016/j.jped.2018.01.008
Tauil, M. C., Sato, A. P. S., & Waldman, E. A. (2016). Factors associated with incomplete or delayed vaccination across countries: a systematic review. Vaccine, 34 (24), 2635-2643. : 10.1016/j.vaccine.2016.04.016.
Unim, B., Saulle, R., Boccalini, S., Taddei, C., Ceccherini, V., Boccia, A., Bonanni, P., & La Torre, G. (2013). Economic evaluation of Varicella vaccination: results of a systematic review. Human vaccines & immunotherapeutics, 9(9), 1932–1942. 10.4161/hv.25228
Varicella vaccination - the global experience. Expert Rev Vaccines. 16(8), 833-843: 10.1080/14760584.2017.1343669.
Vergara-Castañeda, A., Escobar-Gutiérrez, A., Ruiz-Tovar, K., Sotelo, J., Ordoñez, G., Cruz-Rivera, M. Y., & Vaughan, G. (2012). Epidemiologia da varicela no México. Journal of Clinical Virology, 55 (1), p. 51–57. 10.1016 / j.jcv.2012.06.004
Veronesi, R., & Focaccia, R. (2015). Tratado de infectologia (pp. 723-734). (5a Ed.) Atheneu.
Whitley, R. J. (2017). Medicina interna de Harrison (19a ed.), 2, 1175-1183. AMGH.
Widgren, K., Giesecke, J., Lindquist, L., & Tegnell, A. (2016). The burden of chickenpox disease in Sweden. BMC Infect Dis, (16), 666. 10.1186/s12879-016-1957-5
World Health Organization (2014). Varicella and herpes zoster vaccines: WHO position paper. Wkly Epidemiol Rec., 89, 265–288.
World Health Organization (2019). Ten threats to global health in 2019. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019.
Wutzler, P., Bonanni, P., Burgess, M., Gershon, A., Sáfadi, M. A., & Casabona, G. (2017). Varicella vaccination - the global experience. Expert Rev Vaccines, 16(8), 833-843. 10.1080/14760584.2017.1343669.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Camila Lopes Manetti; Bruna Fernandes; Dagna Karen de Oliveira; Dyayne Carla Banovski; Stéphanie Pizatto de Araújo ; Carlos Emanuel Piovezani Brusque; Larissa Panatta; Anna Luiza Maffessoni ; Lara Frangiotto Lopes; Fernanda Morinigo Guevara; João Lucas Lasta; Ianca Pyetra de Almeida; Isadora Maria Pilati Campos; Gabriela Letícia Bonamigo ; Eluan Joel Rodrigues da Silva; Rodolfo dos Santos Barros; Ingrid Nascimento Lima; Geruza Mara Hendges ; Paula Bragato Futagami ; Renata Bragato Futagami
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.